Inspire Medical Systems, Inc. Increase (Decrease) in Receivables
Inspire Medical Systems, Inc. (INSP) reported Increase (Decrease) in Receivables of -$16.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-03
- Inspire Medical Systems, Inc. increase (decrease) in receivables for the quarter ending 2026-06-30 was -$1.93M, a 104.32% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for the quarter ending 2026-03-31 was -$14.29M.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for the quarter ending 2025-12-31 was $11.63M, a 194.61% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for the quarter ending 2025-09-30 was -$29.72M, a 400.22% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for fiscal 2025 was $26.23M, a 908.19% increase from fiscal 2024.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for fiscal 2024 was $2.60M, a 91.39% decline from fiscal 2023.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for fiscal 2023 was $30.22M, a 11.85% increase from fiscal 2022.
- Inspire Medical Systems, Inc. increase (decrease) in receivables for fiscal 2022 was $27.02M, a 192.27% increase from fiscal 2021.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$16.21M 10-Q · filed 2026-08-03 | -$4.58M derived: sum of 3 quarters · filed 2026-08-03 | -$34.30M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$14.29M 10-Q · filed 2026-05-04 | -$2.65M derived: sum of 2 quarters · filed 2026-05-04 | -$32.37M derived: sum of 3 quarters · filed 2026-05-04 | $12.21M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$18.09M derived: sum of 2 quarters · filed 2026-02-13 | $26.50M derived: sum of 3 quarters · filed 2026-08-03 | $26.23M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$29.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $14.86M derived: sum of 2 quarters · filed 2026-08-03 | $14.60M 10-Q · filed 2025-11-03 | $18.55M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $44.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $44.32M 10-Q · filed 2026-08-03 | $48.27M derived: sum of 3 quarters · filed 2026-08-03 | $58.17M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$263.00K 10-Q · filed 2026-05-04 | $3.69M derived: sum of 2 quarters · filed 2026-05-04 | $13.59M derived: sum of 3 quarters · filed 2026-05-04 | $21.30M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $13.85M derived: sum of 2 quarters · filed 2026-02-13 | $21.56M derived: sum of 3 quarters · filed 2026-02-13 | $2.60M 10-K · filed 2026-02-13 |
| 2024-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $17.61M derived: sum of 2 quarters · filed 2025-11-03 | -$1.35M 10-Q · filed 2025-11-03 | $17.28M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $7.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$11.25M 10-Q · filed 2025-08-04 | $7.38M derived: sum of 3 quarters · filed 2026-02-13 | $15.86M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$18.96M 10-Q · filed 2025-05-05 | -$332.00K derived: sum of 2 quarters · filed 2026-02-13 | $8.14M derived: sum of 3 quarters · filed 2026-02-13 | $12.74M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $18.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $27.10M derived: sum of 2 quarters · filed 2026-02-13 | $31.71M derived: sum of 3 quarters · filed 2026-02-13 | $30.22M 10-K · filed 2026-02-13 |
| 2023-09-30 | $8.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $13.08M derived: sum of 2 quarters · filed 2024-11-04 | $11.59M 10-Q · filed 2024-11-04 | $24.21M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.12M 10-Q · filed 2024-08-06 | $15.74M derived: sum of 3 quarters · filed 2025-02-10 | $23.93M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$1.49M 10-Q · filed 2024-05-07 | $11.13M derived: sum of 2 quarters · filed 2025-02-10 | $19.32M derived: sum of 3 quarters · filed 2025-02-10 | $25.15M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $12.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $20.81M derived: sum of 2 quarters · filed 2025-02-10 | $26.64M derived: sum of 3 quarters · filed 2025-02-10 | $27.02M 10-K · filed 2025-02-10 |
| 2022-09-30 | $8.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $14.01M derived: sum of 2 quarters · filed 2023-11-07 | $14.39M 10-Q · filed 2023-11-07 | $21.90M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $6.21M 10-Q · filed 2023-08-01 | $13.71M derived: sum of 3 quarters · filed 2024-02-09 | $15.58M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $382.00K 10-Q · filed 2023-05-02 | $7.88M derived: sum of 2 quarters · filed 2024-02-09 | $9.75M derived: sum of 3 quarters · filed 2024-02-09 | $13.01M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $9.37M derived: sum of 2 quarters · filed 2024-02-09 | $12.63M derived: sum of 3 quarters · filed 2024-02-09 | $9.24M 10-K · filed 2024-02-09 |
| 2021-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.12M derived: sum of 2 quarters · filed 2022-11-01 | $1.74M 10-Q · filed 2022-11-01 | $5.66M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$126.00K 10-Q · filed 2022-08-02 | $3.79M derived: sum of 3 quarters · filed 2023-02-10 | $14.62M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | -$3.38M 10-Q · filed 2022-05-03 | $540.00K derived: sum of 2 quarters · filed 2023-02-10 | $11.37M derived: sum of 3 quarters · filed 2023-02-10 | $10.55M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $14.75M derived: sum of 2 quarters · filed 2023-02-10 | $13.93M derived: sum of 3 quarters · filed 2023-02-10 | $11.84M 10-K · filed 2023-02-10 |
| 2020-09-30 | $10.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $10.01M derived: sum of 2 quarters · filed 2021-11-02 | $7.92M 10-Q · filed 2021-11-02 | $10.02M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$813.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$2.90M 10-Q · filed 2021-08-03 | -$803.00K derived: sum of 3 quarters · filed 2022-02-15 | $774.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$2.09M 10-Q · filed 2021-05-04 | $10.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.59M derived: sum of 3 quarters · filed 2022-02-15 | $4.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.68M derived: sum of 2 quarters · filed 2022-02-15 | $6.09M derived: sum of 3 quarters · filed 2022-02-15 | $6.48M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $3.99M derived: sum of 2 quarters · filed 2020-11-02 | $4.38M 10-Q · filed 2020-11-02 | $5.66M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.80M 10-Q · filed 2020-08-04 | $4.08M derived: sum of 3 quarters · filed 2021-02-24 | $5.01M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $385.00K 10-Q · filed 2020-05-05 | $1.67M derived: sum of 2 quarters · filed 2021-02-24 | $2.59M derived: sum of 3 quarters · filed 2021-02-24 | $3.62M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.21M derived: sum of 2 quarters · filed 2021-02-24 | $3.23M derived: sum of 3 quarters · filed 2021-02-24 | $2.84M 10-K · filed 2021-02-24 |
| 2018-09-30 | $922.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.95M derived: sum of 2 quarters · filed 2019-11-05 | $1.55M 10-Q · filed 2019-11-05 | $2.21M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $630.00K 10-Q · filed 2019-08-06 | $1.29M derived: sum of 3 quarters · filed 2020-02-25 | $1.97M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$399.00K 10-Q · filed 2019-05-07 | $263.00K derived: sum of 2 quarters · filed 2020-02-25 | $944.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.18M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.34M derived: sum of 2 quarters · filed 2020-02-25 | $1.58M derived: sum of 3 quarters · filed 2020-02-25 | $1.77M 10-K · filed 2020-02-25 |
| 2017-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $917.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.10M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $424.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $188.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $760.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |